PriceTracker GLP-1

Status · GLP-1 shortage · checked Oct 3, 2026

GLP-1 shortage status: semaglutide and tirzepatide resolved

As of Oct 3, 2026, FDA's drug shortage database lists both semaglutide injection and tirzepatide injection as resolved; FDA declared the tirzepatide shortage over on Dec 19, 2024 and the semaglutide shortage over on Feb 21, 2025.

Julian CaraulaniFounder, PriceTracker GLP-1Sources read Oct 3

Question: Is there a GLP-1 shortage? · Checked Oct 3, 2026 · Re-checked monthly

Cheapest GLP-1 right now$69/mo at SnagRx, billed monthly. Checked Oct 2.

$69/mo at SnagRx on SnagRx’s site ↗

Status

ItemStatusSinceSource
Semaglutide injection (Wegovy, Ozempic)ResolvedFeb 21, 2025FDA drug shortage database
Tirzepatide injection (Zepbound, Mounjaro)ResolvedDec 19, 2024FDA drug shortage database
Semaglutide and tirzepatide on FDA's shortage listNot listedApr 1, 2026 (FDA statement)FDA, 4/1/2026 update

In the regulator’s own words

"FDA has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved."
FDA, 2/21/2025 update, read Oct 3, 2026
"Today, FDA has issued a new decision determining the tirzepatide injection shortage is resolved."
FDA, 12/19/2024 update, read Oct 3, 2026

This page reports what the regulator has published, in its words. It is not legal or medical advice.

Related

Statuses change. Prices change more.

One email a week: the cheapest GLP-1 program and any real price moves.

Compare every GLP-1